ARTICLE | Clinical News
Anadis preclinical data
August 25, 2008 7:00 AM UTC
In an animal model of influenza, Anadis' nasal spray formulation of polyclonal antibodies reduced the likelihood and severity of influenza infection. The spray inhibited virus replication in the respi...